NEW YORK (GenomeWeb News) – Rodney Markin has joined Trovagene's board of directors, and Chris McGuigan has resigned from the company's board to focus on other opportunities, Trovagene said this week.

Markin is chairman of Transgenomic, chief technology officer and associate vice chancellor for business development at the University of Nebraska Medical Center, and a professor of pathology and microbiology and surgery at the university.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.